An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients

Part of paid clinical trials in East Windsor, New Jersey.

Sponsor
Psoriasis Treatment Center of Central New Jersey
Study ID
NCT03392337
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Narrowband UVB phototherapy — DEVICE
    Ultraviolet B phototherapy

Study Details

A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of response.

Key Dates

Start date
Nov 7, 2017
Status verified
Jan 2019
Primary completion
Dec 1, 2019
Completion
Jan 1, 2020

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Open Label Narrowband UVB phototherapy
    Open Label Narrowband UVB phototherapy for 12 weeks.

Primary Outcome Measure

Psoriasis area severity index score [ Time Frame: 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Elise NelsonEast WindsorNew Jersey08520
Jerry Bagel
[email protected]
609-443-4500
Elise Nelson
6094434500
Jerry Bagel, MD (PRINCIPAL_INVESTIGATOR)
Brian R Keegan, MD, PhD (SUB_INVESTIGATOR)
David S Nieves, MD (SUB_INVESTIGATOR)

Find similar trials in East Windsor, NJ

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Elise Nelson· East Windsor, NJ

Related Studies